Skip to content

PolyNaut®, ViaNautis’ proprietary technology platform, has multiple attributes that address the shortcomings of other drug delivery technologies including:

cell specificity

ability to re-dose

lack of immunogenicity

broad range of genetic cargoes

ability to cross the blood brain barrier (BBB) and reach the brain intact

PolyNaut® Mechanism of Action

PolyNaut is a powerful technology platform for intracellular delivery of a wide range of therapeutic modalities. Bespoke phenotypic targeting is used to allow penetration of selected biological barriers. .

PolyNaut® the actively targeted nanoparticle


  • High stability in biological fluids
  • Enhanced tissue penetration


  • Multiple cargo encapsulation
  • pH triggered release


  • Phenotypic targeting
  • Delivers to and enters cells of choice


ViaNautis is working on a pipeline in CNS and cystic fibrosis.

Collaboration and Partnering

ViaNautis is developing an internal pipeline of products and licencing its platform to partners with proprietary molecules, producing multiple value inflexion points for the company.

The company is working in collaboration with top tier pharmaceutical partners on feasibility studies which may lead to a licence to the technology for specific molecules and indications.

For more information on partnering with us, please contact us.

Back To Top